Molecular genetic predictors for the development of ovarian hyperstimulation syndrome in an IVF program
- Authors: Strelchenko D.A.1, Perminova S.G.1, Donnikov A.E.1,2, Kadochnikova V.V2, Abramov D.D.3,2, Korneeva I.E.1, Saroyan T.T.1, Abubakirov I.N.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- OOO "DNA Technology Research-and-Production Firm"
- National Research Center "Institute of Immunology", Federal Biomedical Agency of Russia
- Issue: No 4 (2016)
- Pages: 56-63
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247640
- DOI: https://doi.org/10.18565/aig.2016.4.56-63
- ID: 247640
Cite item
Abstract
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Daria Andreevna Strelchenko
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: da_strelchenko@mail.ru
graduate student
Svetlana Grigorievna Perminova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: perisvet@list.ru
MD, Leading Researcher of the 1st gynecological department
Andrey Evgenyevich Donnikov
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; OOO "DNA Technology Research-and-Production Firm"
Email: a_donnikov@oparina4.ru
PhD, senior staff scientist of laboratory of molecular genetic methods
V. V Kadochnikova
OOO "DNA Technology Research-and-Production Firm"
Email: kadochnikova@dna-technology.ru
Dmitry Dmitrievich Abramov
National Research Center "Institute of Immunology", Federal Biomedical Agency of Russia; OOO "DNA Technology Research-and-Production Firm"
Email: d.d.abramov@mail.ru
PhD, senior staff scientist of laboratory of molecular immunogenetic
Irina Evgenyevna Korneeva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: irina.korneeva@inbox.ru
MD, Leading Researcher of the 1st gynecological department
Tatevik Tigrani Saroyan
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: tata-l976@mail.ru
PhD, staff scientist of the 1st gynecological department
Idar Nazimovich Abubakirov
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: nondoc555@yahoo.ru
PhD, head of the 1st gynecological department
References
- Madill J.J., Mullen N.B., Harrison B.P. Ovarian hyperstimulation syndrome: a potentially fatal complication of early pregnancy. J. Emerg. Med. 2008; 35(3): 283-6.
- Alama P., Bellver J., Vidal C., Giles J. GnRH analogues in the prevention of ovarian hyperstimulation syndrome. Int. J. Endocrinol. Metab. 2013 Spring; 11(2): 107-16.
- Корнеева И.Е., Калинина Е.А., Сароян Т.Т., Смольникова В.Ю., Серебренникова К.Г., Пырегов А.В., Сухих Г.Т. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. М.: Российское общество акушеров-гинекологов; 2013. 27с. [Korneeva I.E., Kalinina E.A., Saroyan T.T., Smolnikova V.Yu., Serebrennikova K.G., Pyregov A.V., Sukhikh G.T. Federal clinical guidelines. Diagnosis and treatment of ovarian hyperstimulation syndrome. Moscow: Russian Society of Obstetricians and Gynecologists; 2013. 27p. (in Rusian)]
- Marzal А., Holzer Н., Tulandi Т. Future developments to minimize ART risks. Semin. Reprod. Med. 2012; 30(2): 152-60.
- Владимирова И.В., Калинина Е.А., Донников А.Е. Молекулярно-генетические маркеры как прогностические факторы овариального ответа в программах ВРТ. Акушерство и гинекология. 2014; 3: 16-20. [Vladimirova I.V., Kalinina E.A., Donnikov A.E. Molecular genetic markers as prognostic factors of an ovarian response in assisted reproductive technology programs. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2014; 3: 16-20. (in Russian)]
- Nordhoff V., Gromoll J., Simoni M. Constitutively active mutations of G protein coupled receptors: the case of the human luteinizing hormone and follicle-stimulating hormone receptors. Arch. Med. Res. 1999; 30(6): 501-9.
- Simoni M., Tempfer C.B., Destenaves B., Fauser B. Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response. Hum. Reprod. Update. 2008; 14(5): 459-84.
- Golan A., Ronel R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv. 1989; 44(6): 430-40.
- Schenker J.G. Ovarian hyperstimulation syndrome. In: Wallach E.E., Zacur H A., eds. Reproductive medicine and surgery. St Louis: Mosby; l995: 649-79.
- Kwee J., Elting M.E., Schats R., McDonnell J., Lambalk C.B. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod. Biol. Endocrinol. 2007; 5: 9.
- Lee T.H., Liu C.H., Huang C.C., Wu Y.L., Shih Y.T., Ho H.N. et al. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 2008; 23(1): 160-7.
- Humaidan P., Quartarolo J., Papanikolaou E.G. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil. Steril. 2010; 94(2): 389-400.
- Rizk B. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome. Reprod. Biomed. Online. 2009; 19(1): 14-27.
- Alviggi C., Clarizia R., Pettersen K., Mollo A., Humaidan P., Strina I. et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod. Biomed. Online. 2009; 18(1): 9-14.
- O’Brien T.J., Kalmin M.M., Harralson A.F., Clark A.M., Gindoff I., Simmens S.J. et al. Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reprod. Biol. Endocrinol. 2013; 11: 71.
- Hanevik H.I., Hilmarsen H.T., Skjelbred C.F., Tanbo T., Kahn J.A.A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod. Biomed. Online. 2011; 23(1): 97-104.
- Fiedler K., Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod. Biol. Endocrinol. 2012; 10: 32.
- Cerrillo M., Pacheco A., Rodriguez S., Gomez R., Delgado F., Pellicer A. et al. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertil. Steril. 2011; 95(8): 2517-9.
- Wang T.H., Horng S.G., Chang C.L., Wu H.M., Tsai Y.J., Wang H.S. et al. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J. Clin. Endocrinol. Metab. 2002; 87(7): 3300-8.
- Park J.E., Chen H.H., Winer J., Houck K.A., Ferrara N. J. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 1994; 269(41): 25646-54.
- Hanevik H.I., Hilmarsen H.T., Skjelbred C.F. Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype. Gynecol. Endocrinol. 2012; 28(11): 845-9.
- Nouri K., Haslinger P., Szabo L., Sator M., Schreiber M., Schneeberger C. et al. Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study. J. Ovarian Res. 2014; 7: 54.
- Borna S., Nasery A. Spontaneous ovarian hyperstimulation in a pregnant woman with hypothyroidism. Fertil. Steril. 2007; 88(3): 705. e1-3.
- Delbaere A., Smits G., Olantunbosun O., Pierson R., Vassart G., Costagliola S. New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum. Reprod. 2004; 19(3): 486-9.
- Guvenal F., Guvenal T., Timuroglu Y., Timuroglu T., Cetin M. Spontaneous ovarian hyperstimulation-like reaction caused by primary hypothyroidism. Acta Obstet. Gynecol. Scand. 2006; 85(1): 124-5.
- Taher B.M., Ghariabeh R.A., Jarrah N.S., Hadidy A.M., Radaideh A.M., Ajlouni K.M. Spontaneous ovarian hyperstimulation syndrome caused by hypothyroidism in an adult. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004; 112(1): 107-9.
- Edwards-Silva R.N., Han C.S., Hoang Y., Kao L.C. Spontaneous ovarian hyperstimulation in a naturally conceived pregnancy with uncontrolled hypothyroidism. Obstet. Gynecol. 2008; 111(2, Pt 2): 498-501.
- Фадеев В.В., Перминова С.Г., Назаренко Т.А., Корнеева И.Е., Мельниченко Г.А., Дедов И.И. Заболевания щитовидной железы и репродуктивная функция женщины. Пособие для врачей. М.: МАИ-ПРИНТ; 2009. [Fadeev V.V., Perminova S.G., Nazarenko T.A., Korneeva I.E., Melnichenko G.A., Dedov I.I. Diseases of the thyroid gland and reproduc tive function of women. Manual for physicians. Moscow: MAI-PRINT; 2009. (in Russian)]
- Ashrafi M., Bahmanabadi A., Akhond M.R., Arabipoor A. Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model. Arch. Gynecol. Obstet. 2015; 292(5): 1145-52.
- Dewailly D., Andersen C.Y., Balen A., Broekmans F., Dilaver N., Fanchin R. et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum. Reprod. Update. 2014; 20(3): 370-85.
- Brodin T., Hadziosmanovic N., Berglund L., Olovsson M., Holte J. Comparing four ovarian reserve markers - associations with ovarian response and live births after assisted reproduction. Acta Obstet. Gynecol. Scand. 2015; 94(10): 1056-63.
Supplementary files
![](/img/style/loading.gif)